JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Investigador en el periodo 1986-2013
Gustave Roussy Cancer Campus
Villejuif, FranciaPublicaciones en colaboración con investigadores/as de Gustave Roussy Cancer Campus (2)
2012
-
Phase i studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
Investigational New Drugs, Vol. 30, Núm. 3, pp. 1121-1131
2007
-
The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib
Oncologist, Vol. 12, Núm. 3, pp. 281-290